BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 31171433)

  • 1. Moral distress among community pharmacists: causes and achievable remedies.
    Astbury JL; Gallagher CT
    Res Social Adm Pharm; 2020 Mar; 16(3):321-328. PubMed ID: 31171433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and validation of a questionnaire to measure moral distress in community pharmacists.
    Astbury JL; Gallagher CT
    Int J Clin Pharm; 2017 Feb; 39(1):156-164. PubMed ID: 28004238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The issue of moral distress in community pharmacy practice: background and research agenda.
    Astbury JL; Gallagher CT; O'Neill RC
    Int J Pharm Pract; 2015 Oct; 23(5):361-6. PubMed ID: 25639156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Moral reasoning among Dutch community pharmacists: testing the applicability of the Australian Professional Ethics in Pharmacy test.
    Kruijtbosch M; Göttgens-Jansen W; Floor-Schreudering A; van Leeuwen E; Bouvy ML
    Int J Clin Pharm; 2019 Oct; 41(5):1323-1331. PubMed ID: 31254151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Moral dilemmas of community pharmacists: a narrative study.
    Kruijtbosch M; Göttgens-Jansen W; Floor-Schreudering A; van Leeuwen E; Bouvy ML
    Int J Clin Pharm; 2018 Feb; 40(1):74-83. PubMed ID: 29159520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measuring moral distress in pharmacy and clinical practice.
    Sporrong SK; Höglund AT; Arnetz B
    Nurs Ethics; 2006 Jul; 13(4):416-27. PubMed ID: 16838572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Moral dilemmas reflect professional core values of pharmacists in community pharmacy.
    Kruijtbosch M; Göttgens-Jansen W; Floor-Schreudering A; van Leeuwen E; Bouvy ML
    Int J Pharm Pract; 2019 Apr; 27(2):140-148. PubMed ID: 30338875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Moral reasoning perspectives of community pharmacists in situations of drug shortages.
    Kruijtbosch M; Floor-Schreudering A; van Leeuwen E; Göttgens-Jansen W; Bouvy ML
    Res Social Adm Pharm; 2022 Mar; 18(3):2424-2431. PubMed ID: 33349586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The corporatization of community pharmacy: implications for service provision, the public health function, and pharmacy's claims to professional status in the United Kingdom.
    Bush J; Langley CA; Wilson KA
    Res Social Adm Pharm; 2009 Dec; 5(4):305-18. PubMed ID: 19962674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Professional ethics in pharmacy practice: developing a psychometric measure of moral reasoning.
    Chaar BB
    Pharm World Sci; 2009 Aug; 31(4):439-449. PubMed ID: 19308668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of an instrument to measure moral distress within the Australian residential and community care environments.
    Burston A; Eley R; Parker D; Tuckett A
    Int J Older People Nurs; 2017 Jun; 12(2):. PubMed ID: 28008747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship between pharmacists' tenure in community setting and moral reasoning.
    Latif DA
    J Bus Ethics; 2001 May; 31(2):131-41. PubMed ID: 11840998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Self-reported clinical pharmacy service provision in Austria: an analysis of both the community and hospital pharmacy sector-a national study.
    Deibl S; Mueller D; Kirchdorfer K; Stemer G; Hoppel M; Weidmann AE
    Int J Clin Pharm; 2020 Aug; 42(4):1050-1060. PubMed ID: 32494989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. "We are white coats whirling round"--moral distress in Swedish pharmacies.
    Sporrong SK; Höglund AT; Hansson MG; Westerholm P; Arnetz B
    Pharm World Sci; 2005 Jun; 27(3):223-9. PubMed ID: 16096892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Living with conflicts-ethical dilemmas and moral distress in the health care system.
    Kälvemark S; Höglund AT; Hansson MG; Westerholm P; Arnetz B
    Soc Sci Med; 2004 Mar; 58(6):1075-84. PubMed ID: 14723903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implementation of a mental health medication management intervention in Australian community pharmacies: Facilitators and challenges.
    Hattingh HL; Kelly F; Fowler J; Wheeler AJ
    Res Social Adm Pharm; 2017; 13(5):969-979. PubMed ID: 28583302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ethical, religious and factual beliefs about the supply of emergency hormonal contraception by UK community pharmacists.
    Cooper RJ; Bissell P; Wingfield J
    J Fam Plann Reprod Health Care; 2008 Jan; 34(1):47-50. PubMed ID: 18201407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A qualitative study of pharmacists' perspectives on the supply of emergency hormonal contraception via patient group direction in the UK.
    Bissell P; Savage I; Anderson C
    Contraception; 2006 Mar; 73(3):265-70. PubMed ID: 16472568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacists' concerns and perceived benefits from the deregulation of hormonal emergency contraception (HEC).
    Blackwell D; Cooper N; Taylor G; Holden K
    Br J Fam Plann; 1999 Oct; 25(3):100-4. PubMed ID: 10567059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implementing oral chemotherapy services in community pharmacies: a qualitative study of chemotherapy nurses' and pharmacists' views.
    Butt F; Ream E
    Int J Pharm Pract; 2016 May; 24(3):149-59. PubMed ID: 26671523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.